Raquel Aloyz Selected Research

IC486241

8/2012

Effects of the novel DNA dependent protein kinase inhibitor, IC486241, on the DNA damage response to doxorubicin and cisplatin in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raquel Aloyz Research Topics

Disease

10	Neoplasms (Cancer) 01/2020 - 03/2002
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 06/2007
5	Breast Neoplasms (Breast Cancer) 11/2018 - 03/2007
4	Colonic Neoplasms (Colon Cancer) 07/2015 - 06/2012
2	Hyperglycemia 01/2020 - 01/2019
2	Neoplasm Metastasis (Metastasis) 11/2018 - 01/2011
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2013 - 09/2011
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2010 - 05/2010
1	Hypertension (High Blood Pressure) 01/2020
1	Triple Negative Breast Neoplasms 01/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2015
1	Fanconi Anemia (Fanconi's Anemia) 05/2013
1	Ovarian Neoplasms (Ovarian Cancer) 04/2013
1	Carcinogenesis 01/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2010
1	Glioma (Gliomas) 10/2002

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 03/2002
3	Dasatinib (BMS 354825)FDA Link 01/2017 - 05/2010
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2015 - 06/2012
3	Biological ProductsIBA 01/2013 - 10/2002
3	Chlorambucil (Leukeran)FDA Link 09/2011 - 06/2007
2	NVP-BKM120IBA 01/2020 - 07/2013
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2015 - 04/2013
2	veliparibIBA 01/2015 - 04/2013
2	Phosphotransferases (Kinase)IBA 07/2013 - 05/2010
2	Proteins (Proteins, Gene)FDA Link 05/2013 - 01/2011
2	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 08/2012 - 06/2012
2	Imatinib Mesylate (Gleevec)FDA Link 09/2011 - 09/2011
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	ibrutinibIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	AlkaloidsIBA 11/2018
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2018
1	ME0328IBA 11/2018
1	olaparibIBA 11/2018
1	Fluorouracil (Carac)FDA LinkGeneric 07/2015
1	Formaldehyde (Formol)FDA Link 07/2015
1	ParaffinIBA 07/2015
1	3- amino- 6- (4- (methylsulfonyl)phenyl)- N- phenylpyrazine- 2- carboxamideIBA 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2015
1	Topoisomerase I InhibitorsIBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 12/2013
1	Temozolomide (Temodar)FDA LinkGeneric 04/2013
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2013
1	imetelstatIBA 01/2013
1	DNA-Activated Protein KinaseIBA 08/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2012
1	Cisplatin (Platino)FDA LinkGeneric 08/2012
1	IC486241IBA 08/2012
1	Phenobarbital (Luminal)FDA Link 01/2011
1	A-Form DNA (A-DNA)IBA 01/2011
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2011
1	src-Family KinasesIBA 05/2010
1	CalciumIBA 05/2010
1	Small Interfering RNA (siRNA)IBA 03/2007
1	NitrogenIBA 03/2002
1	Mechlorethamine (Nitrogen Mustard)FDA Link 03/2002

Therapy/Procedure

7	Therapeutics 01/2017 - 01/2010
2	Drug Therapy (Chemotherapy) 01/2015 - 04/2013